Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
03 2023
Historique:
revised: 17 01 2023
received: 09 12 2022
accepted: 23 01 2023
pubmed: 6 2 2023
medline: 15 3 2023
entrez: 5 2 2023
Statut: ppublish

Résumé

Proximal cap ambiguity is a key parameter in the global chronic total occlusion (CTO) percutaneous coronary intervention (PCI) crossing algorithm. We examined the baseline characteristics and procedural outcomes of 9718 CTO PCIs performed in 9498 patients at 41 US and non-US centers between 2012 and 2022. Proximal cap ambiguity was present in 35% of CTO lesions. Patients whose lesions had proximal cap ambiguity were more likely to have had prior coronary artery bypass graft surgery (37% vs. 24%; p < 0.001). Lesions with proximal cap ambiguity were more complex with higher J-CTO score (3.1 ± 1.0 vs. 2.0 ± 1.2; p < 0.001) and lower technical (79% vs. 90%; p < 0.001) and procedural (77% vs. 89%; p < 0.001) success rates compared with nonambiguous CTO lesions. The incidence of major adverse cardiovascular events (MACE) was higher in cases with proximal cap ambiguity (2.5% vs. 1.7%; p < 0.001). The retrograde approach was more commonly used among cases with ambiguous proximal cap (50% vs. 21%; p < 0.001) and was more likely to be the final successful crossing strategy (29% vs. 13%; p < 0.001). The antegrade dissection and re-entry (ADR) "move-the-cap" techniques were also more common among cases with proximal cap ambiguity. Proximal cap ambiguity in CTO lesions is associated with higher utilization of the retrograde approach and ADR, lower technical and procedural success rates, and higher incidence of in-hospital MACE.

Sections du résumé

BACKGROUND
Proximal cap ambiguity is a key parameter in the global chronic total occlusion (CTO) percutaneous coronary intervention (PCI) crossing algorithm.
METHODS
We examined the baseline characteristics and procedural outcomes of 9718 CTO PCIs performed in 9498 patients at 41 US and non-US centers between 2012 and 2022.
RESULTS
Proximal cap ambiguity was present in 35% of CTO lesions. Patients whose lesions had proximal cap ambiguity were more likely to have had prior coronary artery bypass graft surgery (37% vs. 24%; p < 0.001). Lesions with proximal cap ambiguity were more complex with higher J-CTO score (3.1 ± 1.0 vs. 2.0 ± 1.2; p < 0.001) and lower technical (79% vs. 90%; p < 0.001) and procedural (77% vs. 89%; p < 0.001) success rates compared with nonambiguous CTO lesions. The incidence of major adverse cardiovascular events (MACE) was higher in cases with proximal cap ambiguity (2.5% vs. 1.7%; p < 0.001). The retrograde approach was more commonly used among cases with ambiguous proximal cap (50% vs. 21%; p < 0.001) and was more likely to be the final successful crossing strategy (29% vs. 13%; p < 0.001). The antegrade dissection and re-entry (ADR) "move-the-cap" techniques were also more common among cases with proximal cap ambiguity.
CONCLUSIONS
Proximal cap ambiguity in CTO lesions is associated with higher utilization of the retrograde approach and ADR, lower technical and procedural success rates, and higher incidence of in-hospital MACE.

Identifiants

pubmed: 36740235
doi: 10.1002/ccd.30580
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

737-746

Subventions

Organisme : The authors are grateful for the philanthropic support of our generous anonymous donors, and the philanthropic support of Drs. Mary Ann and Donald A Sens, Mrs. Diane and Dr. Cline Hickok, Mrs. Wilma and Mr. Dale Johnson, Mrs. Charlotte and Mr. Jerry Golinvaux Family Fund, the Roehl Family Foundation and the Joseph Durda Foundation. The generous gifts of these donors to the Minneapolis Heart Institute Foundation's Science Center for Coronary Artery Disease (CCAD) helped support this research project

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Brilakis ES, Mashayekhi K, Tsuchikane E, et al. Guiding principles for chronic total occlusion percutaneous coronary intervention: a global expert consensus document. Circulation. 2019;140:420-433.
Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations. Circulation. 2021;143:479-500.
Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm. J Am Coll Cardiol. 2021;78:840-853.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377-381.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-2035.
Morino Y, Abe M, Morimoto T, et al. Investigators JCR predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. JACC Cardiovasc Interv. 2011;4:213-221.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions. JACC Cardiovasc Interv. 2016;9:1-9.
Simsek B, Kostantinis S, Karacsonyi J, et al. Predicting periprocedural complications in chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Interv. 2022;15:1413-1422.
Hanratty C, Walsh S. Procedure planning: anatomical determinants of strategy. Curr Cardiol Rev. 2014;10:108-119.
Opolski MP, Nap A, Knaapen P. A computed tomography algorithm for crossing coronary chronic total occlusions: riding on the wave of the proximal cap and distal vessel segment. Neth Heart J. 2021;29:42-51.
Werner GS. Use of coronary computed tomographic angiography to facilitate percutaneous coronary intervention of chronic total occlusions. Circ Cardiovasc Interv. 2019;12:e007387.
Hong SJ, Kim BK, Cho I, et al. Effect of coronary CTA on chronic total occlusion percutaneous coronary intervention. JACC Cardiovasc Imaging. 2021;14:1993-2004.
Galassi AR, Sumitsuji S, Boukhris M, et al. Utility of intravascular ultrasound in percutaneous revascularization of chronic total occlusions. JACC Cardiovasc Interv. 2016;9:1979-1991.
Karacsonyi J, Alaswad K, Jaffer FA, et al. Use of intravascular imaging during chronic total occlusion percutaneous coronary intervention: insights from a contemporary multicenter registry. J Am Heart Assoc. 2016;5(8):e003890.
Simsek B, Kostantinis S, Karacsonyi J, et al. Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry. Catheter Cardiovasc Interv. 2022;100:19-27.
Megaly M, Xenogiannis I, Abi Rafeh N, et al. Retrograde approach to chronic total occlusion percutaneous coronary intervention. Circ Cardiovasc Interv. 2020;13:e008900.
Vo MN, Karmpaliotis D, Brilakis ES. Move the cap” technique for ambiguous or impenetrable proximal cap of coronary total occlusion: move the cap technique. Catheter Cardiovasc Interv. 2016;87:742-748.
Roy J, Hill J, Spratt JC. The “side-BASE technique”: combined side branch anchor balloon and balloon assisted sub-intimal entry to resolve ambiguous proximal cap chronic total occlusions. Catheter Cardiovasc Interv. 2018;92:E15-E19.
Carlino M, Godino C, Latib A, Moses JW, Colombo A. Subintimal tracking and re-entry technique with contrast guidance: a safer approach. Catheter Cardiovasc Interv. 2008;72:790-796.
Karatasakis A, Danek BA, Karmpaliotis D, et al. Impact of proximal cap ambiguity on outcomes of chronic total occlusion percutaneous coronary intervention: insights from a multicenter US registry. J Invasive Cardiol. 2016;28:391-396.
Simsek B, Kostantinis S, Karacsonyi J, et al. Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction. Catheter Cardiovasc Interv. 2022;99:1059-1064.
Simsek B, Kostantinis S, Karacsonyi J, et al. International percutaneous coronary intervention complication survey. Catheter Cardiovasc Interv. 2022;99:1733-1740.
Kostantinis S, Simsek B, Karacsonyi J, et al. In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion. EuroIntervention. 2022;18:e929-e932.

Auteurs

Spyridon Kostantinis (S)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Bahadir Simsek (B)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Judit Karacsonyi (J)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Athanasios Rempakos (A)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Khaldoon Alaswad (K)

Henry Ford Cardiovascular Division, Detroit, Minnesota, USA.

Michael Megaly (M)

Henry Ford Cardiovascular Division, Detroit, Minnesota, USA.

Oleg Krestyaninov (O)

Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dmitrii Khelimskii (D)

Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dimitrios Karmpaliotis (D)

Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, New Jersey, USA.

Farouc A Jaffer (FA)

Massachusetts General Hospital, Boston, Massachusetts, USA.

Jaikirshan J Khatri (JJ)

Cleveland Clinic, Cleveland, Ohio, USA.

Paul Poommipanit (P)

University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

Mitul P Patel (MP)

UCSD Medical Center, La Jolla, California, USA.

Ehtisham Mahmud (E)

UCSD Medical Center, La Jolla, California, USA.

Michael Koutouzis (M)

Red Cross Hospital of Athens, Athens, Greece.

Ioannis Tsiafoutis (I)

Red Cross Hospital of Athens, Athens, Greece.

Sevket Gorgulu (S)

Biruni University Medical School, Istanbul, Turkey.

Basem Elbarouni (B)

St. Boniface General Hospital, Winnipeg, Manitoba, Canada.

William Nicholson (W)

Emory University Hospital Midtown, Atlanta, Georgia, USA.

Wissam Jaber (W)

Emory University Hospital Midtown, Atlanta, Georgia, USA.

Stephane Rinfret (S)

Emory University Hospital Midtown, Atlanta, Georgia, USA.

Nidal Abi Rafeh (N)

North Oaks Health System, Hammond, Louisiana, USA.

Omer Goktekin (O)

Memorial Bahcelievler Hospital, Istanbul, Turkey.

Ahmed M ElGuindy (AM)

Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt.

Salman S Allana (SS)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Bavana V Rangan (BV)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Yader Sandoval (Y)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

M Nicholas Burke (MN)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH